Immunex Corporation

Lymphokines for therapeutic use as anti-cancer agents supporting the human immune system

  • Year invested 1992
  • Investment Stage Public/PIPES
  • Sectors
  • Investment Status Historic
  • Company Status IPO/Public (by Amgen)